Cartesian Therapeutics, Inc. — Director's Dealing 2021

Sep 22, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SELECTA BIOSCIENCES INC (SELB)
CIK: 0001453687
Period of Report: 2021-09-20

Reporting Person: Tan Kevin (Chief Financial Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-09-20	Employee Stock Option (right to buy)	$4.17	A	750000	Acquired	2031-09-19	Common Stock (750000.0)	Direct

Footnotes

F1: This option will vest as to 25% on September 20, 2022. The remainder of the underlying shares will vest in 36 equal monthly installments thereafter.